AUSTIN, TX / ACCESS Newswire / February 13, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of ...

Encoded Therapeutics is shrinking its headcount by 29% as the gene therapy biotech draws resources away from its early-stage ...

New research has uncovered a surprising silver lining to drought conditions—enhancing the color and quality of grapes by increasing anthocyanin levels through a finely tuned molecular pathway.

EU-funded researchers are investigating the link between mindfulness and health, offering potential new options for the ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DozQrLpG.js ...

By pushing for earlier detection, advocating for an integrated approach to maternal and cardiovascular care, and training ...

Limb regeneration in humans is a fascinating area of science that, for the moment, is not naturally possible as it is in some animals, such as certain species of reptiles or amphib ...

He noted that other assays studied in pancreatic cancer have only examined a handful of samples. "When they publish a second ...

Dr Emma Solly University of Adelaide's Dr Emma Solly and Dr Sivabaskari Pasupathy will share in the latest round of funding from The ...

AUSTIN, TX - Aspira Women's Health Inc. (NASDAQ:AWH), a micro-cap company with a market value of approximately $5 million specializing in the development of diagnostic tools for gynecologic diseases, ...

Fifth Subject in BB-301 Phase 1b/2a Clinical Treatment Study safely treated in February 2025--Interim clinical study update to be presented in ...